Picture of Consun Pharmaceutical logo

1681 — Consun Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Consun Pharmaceutical Group Posts FY Profit Attributable Of RMB465.4 Mln

March 20 (Reuters) - Consun Pharmaceutical Group Ltd
 1681.HK :
    * PROPOSED TO DECLARE A FINAL DIVIDEND OF HKD0.20 PER SHARE
FOR
YEAR ENDED 31 DECEMBER 2018
    * FY REVENUE AMOUNTED TO RMB1.84 BILLION, UP ABOUT 11.1%
    * FY PROFIT ATTRIBUTABLE RMB465.4 MILLION VERSUS RMB396.2
MILLION

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS75nL3G
Further company coverage:  1681.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Consun Pharmaceutical

See all news